Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg
12:08pm, Monday, 04'th Oct 2021
Guardant Health Inc (NASDAQ: GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ: NEO), Bloomberg reported citing people familiar with the matter. Related: Guardan
GH Stock Price: Why It Fell 14%
02:57pm, Saturday, 02'nd Oct 2021
The stock price of Guardant Health Inc (NASDAQ: GH) fell by 14% in the previous trading session. This is why it happened.
Why Guardant Health Is Down More Than 14% Friday
01:13pm, Friday, 01'st Oct 2021
Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.
Guardant Health Weighing NeoGenomics Acquisition: Bloomberg
11:16am, Friday, 01'st Oct 2021
Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar with the matter. Related: Precision O
Investing in These 2 Top Stocks Could Make You a Millionaire Retiree
06:13am, Thursday, 30'th Sep 2021
Both of these companies boast exciting growth prospects.
The 1 Stock I'd Buy Right Now
07:05am, Saturday, 18'th Sep 2021
The pandemic isn't over yet.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importanc
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data demonstrating the ad
Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
04:05pm, Thursday, 02'nd Sep 2021
REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the up
Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
04:15pm, Friday, 06'th Aug 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and
Precision Oncology Sales Boost Guardant Health Q2 Topline, Backs FY21 Outlook, Management Updates
09:35am, Friday, 06'th Aug 2021
After the market close on Thursday, Guardant Health Inc (NASDAQ: GH) reported Q2 revenues increased 39% Y/Y to $92.1 million, beating the consensus of $84.61 million. Guardant's oncology testing re
Guardant Health's (GH) CEO Helmy Eltoukhy on Q2 2021 Results - Earnings Call Transcript
04:09am, Friday, 06'th Aug 2021
Guardant Health's (GH) CEO Helmy Eltoukhy on Q2 2021 Results - Earnings Call Transcript
Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.
05:52am, Sunday, 01'st Aug 2021
There's both rhyme and reason for checking out these four stocks.
SPRINGFIELD, Mo. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Fight Colorectal Cancer (Fight CRC), the nation's leading colorectal cancer (CRC) patient advocacy organization, and Guardant Health, Inc. (Na
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
06:38pm, Monday, 19'th Jul 2021
SEOUL, Souh Korea, July 19, 2021 /PRNewswire/ -- Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of $26 million from Guardant Health, Inc. (Nasdaq: G
